LY2940680

LY2940680 · Eli Lilly and Company

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for LY2940680, covering 2013-08-27 to 2019-10-21. Get the full timeline:

Most recent: Clinical Trial Update: A Study of LY2940680 in Healthy Participants [Phase 1]